Market Place
Sourcing Support
Bionpharma`s Generic Fluvoxamine Maleate Receives Approval in the U.S.
22 Jan 2024 //
FDA
Bionpharma`s Generic Fluvoxamine Maleate Receives Approval in the U.S.
22 Jan 2024 //
FDA
FDA nixes EUA ambitions for Eiger’s COVID treatment
06 Oct 2022 //
FIERCEBIOTECH
FDA rejects cheap, generic SSRI as a Covid-19 drug
17 May 2022 //
ENDPTS
How a Controversial Off-Patent Psychiatric Treatment Went Legit?
21 Jan 2022 //
TRIALSITENEWS
University of Minnesota PI Submits EUA Application to FDA for Fluvoxamine
27 Dec 2021 //
TRIALSITENEWS
Antidepressant fluvoxamine may reduce risk of COVID-19 hospitalisation
27 Oct 2021 //
ECONOMICTIMES
Cheap SSRI drug proves successful in reducing Covid-related hospitalization
27 Oct 2021 //
ENDPTS
Recent Fluvoxamine COVID benefits discovered using Cytel-designed platform trial
13 Sep 2021 //
BUSINESSWIRE
With fluvoxamine, doctors find an old drug that actually work against COVID-19
19 Aug 2021 //
KENTUCKY
OCD drug shows 31% hospitalization reduction in platform trial
12 Aug 2021 //
ENDPTS
Fluvoxamine Data Promising Early Treatment in Patients with Mild COVID-19
06 Oct 2020 //
PRNEWSWIRE
Bionpharma`s Generic Fluvoxamine Maleate Receives Approval in US
15 May 2020 //
FDA
US researchers evaluate antidepressant fluvoxamine for Covid-19
13 May 2020 //
CLINICALTRIALSARENA
Bionpharma`s Generic Fluvoxamine Maleate Receives Tentative Approval in US
20 Feb 2020 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.